Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Fox

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patientsH Sharma, N Thatcher, J Baer, et al.
British Journal of Cancer|August 1, 1993
A phase I study of intravenous bryostatin 1 in patients with advanced cancerJ Prendiville, D Crowther, N Thatcher, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patientsH Sharma, N Thatcher, J Baer, et al.
British Journal of Cancer|August 1, 1993
A phase I study of intravenous bryostatin 1 in patients with advanced cancerJ Prendiville, D Crowther, N Thatcher, et al.
Pageof 10